Jeff Yass’s Organogenesis Holdings ORGO Stock Holding History

Jeff Yass’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,900	Closed	-$56.5K	–	12900
2024 Q1	$56.5K	Sell	19,900 -3,500	-15%	-$11.9K	﹤0.01%	11514
2023 Q4	$95.7K	Buy	+23,400	New	+$65.5K	﹤0.01%	11366
2023 Q1	–	Sell	-13,100	Closed	-$35.2K	–	13219
2022 Q4	$35.2K	Sell	13,100 -7,000	-35%	-$20.4K	﹤0.01%	11569
2022 Q3	$65K	Sell	20,100 -10,000	-33%	-$45.2K	﹤0.01%	12036
2022 Q2	$147K	Sell	30,100 -14,200	-32%	-$87.4K	﹤0.01%	11049
2022 Q1	$338K	Buy	44,300 +6,800	+18%	+$52.6K	﹤0.01%	9984
2021 Q4	$347K	Sell	37,500 -34,600	-48%	-$368K	﹤0.01%	10133
2021 Q3	$1.03M	Buy	72,100 +47,200	+190%	+$733K	﹤0.01%	7493
2021 Q2	$414K	Buy	+24,900	New	+$464K	﹤0.01%	10045

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Jeff Yass's ORGO Position: Q2 2026 in Review

Jeff Yass reduced its Organogenesis Holdings (ORGO) stake by 43% in Q2 2026, selling an estimated $29.9K and leaving 16,064 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #12910.

Jeff Yass first reported a position in ORGO in Q1 2019 and has held it in 21 quarters since. The position peaked at $2.63M in Q2 2021. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Jeff Yass held 16,064 shares of Organogenesis Holdings worth $39K as of Q2 2026.
Jeff Yass sold 12,243 Organogenesis Holdings shares in Q2 2026, an estimated $29.9K.
Organogenesis Holdings made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12910 holding.
Jeff Yass first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 21 quarters since.
Jeff Yass's Organogenesis Holdings position peaked at $2.63M in Q2 2021.
134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.